PER 2.50% 8.2¢ percheron therapeutics limited

Any indication that results are positive will see Sarepta jump...

  1. 964 Posts.
    lightbulb Created with Sketch. 329
    Any indication that results are positive will see Sarepta jump on ANP to compliment their existing DMD drug Eteplirsen which only work with 13% of DMD patients. ATL1102 can be used to reduce inflammation in all DMD patients and for other conditions... we should also be expecting to hear soon about the Phase 11b European trial for ATL1102 which will be run in parallel and the ATL1103 EAP. Plenty of announcements about to drop..
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $145.4K 1.739M

Buyers (Bids)

No. Vol. Price($)
1 69272 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 71037 1
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.